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Gut microbiota and immunity:
possible role in sudden infant death
syndrome
Paul N. Goldwater*
Discipline of Paediatrics, School of Paediatrics and Reproductive Health, University of Adelaide, North Adelaide, SA, Australia
The gut microbiome influences the development of the immune system of young
mammals; the establishment of a normal gut microbiome is thought to be important
for the health of the infant during its early development. As the role of bacteria in the
causation of sudden infant death syndrome (SIDS) is backed by strong evidence, the
balance between host immunity and potential bacterial pathogens is likely to be pivotal.
Bacterial colonization of the infant colon is influenced by age, mode of delivery, diet,
environment, and antibiotic exposure. The gut microbiome influences several systems
including gut integrity and development of the immune system; therefore, gut microflora
could be important in protection against bacteria and/or their toxins identified in SIDS
infants. The aims of the review are to explore (1) the role of the gut microbiome in relation to
the developmentally critical period in which most SIDS cases occur; (2) the mechanisms
by which the gut microbiome might induce inflammation resulting in transit of bacteria
from the lumen into the bloodstream; and (3) assessment of the clinical, physiological,
pathological, and microbiological evidence for bacteremia leading to the final events in
SIDS pathogenesis.
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Introduction
The common bacterial hypothesis (1, 2) and the role of bacteria in the causation of sudden infant
death syndrome (SIDS) have not been considered in depth by mainstream researchers nor has there
been broad interest in the potential contribution of infection and inflammation to these deaths.
Studies on the microbiology of SIDS (3–7) provided explanations for SIDS risk factors and potential
mechanisms in which inflammatory responses could affect abnormal arousal, respiration (8, 9),
and/or brain stem compromise (10); these are areas that have preoccupied the mainstream of SIDS
research for decades without successfully providing hypotheses congruent with epidemiological and
pathological features of SIDS.
The infection model of SIDS stands on substantial evidence identifying: Staphylococcus aureus
and its enterotoxins (11–14); toxigenic Escherichia coli (15, 16); Clostridium perfringens (3, 4); and
recent findings (based on a restricted number of bacterial species identified by culture and PCR)
of significant differences in the gut microbiome between SIDS and healthy babies (17). A review of
the gut microbiome of babies in the context of immunity and immune/inflammatory responses to
bacterial infectionwas considered timely: to help clarify the role of gut/mucosal immunity in relation
to SIDS; to explain the apparent mucosal dysregulation reported for one SIDS infant (18). The basis
for a link between the gut microbiome and SIDS is founded upon published evidence that provides a
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logical explanation of underlying pathomechanisms involved in
SIDS. The evidence is summarized in Table 1 and addressed later
in the review.
Background
It has been known since 1905 that the microbiota of neonates
undergo change with growth and development (19). The type
of early microbiota is important in terms of development of the
immune system, and this could influence susceptibility to infec-
tion, induction of gut inflammation, and adverse outcomes of
infection. Improved understanding of how the gutmicrobiota and
type of feeding affect immune and neurodevelopment has arisen
since the introduction of molecular techniques to identify and
quantify bacterial genera and species involved (17, 20–22).
A literature search reviewed recent publications covering devel-
opment of the infant gut microbiota in conjunction with develop-
ment of the infant immune system and related functions. Articles
pertaining to the gut microbiota and SIDS/sudden unexplained
infant deaths (SUDI) were also reviewed. Search engines used
included PubMed, MedlineRanker, PubCrawler, Google Scholar,
and Open Access Library (OALib).
TABLE 1 | Comparison between findings in SIDS compared to sepsis.
SIDS Sepsis
Pathological
findings
Vasculopathy Vasculopathy
(intra-thoracic
petechial hemorrhages)
Coagulopathy Coagulopathy
(raised FDPs) (raised FDPs)
Heavy, wet, congested lungs Heavy, wet, congested lungs
Renal shutdown Renal shutdown
(empty bladder)
Evidence of recent
pro-inflammatory cytokine
release
Evidence of recent
pro-inflammatory cytokine
release
Cerebro-spinal microgliosis ?Cerebro-spinal microgliosis
Vasculopathy Vasculopathy
Coagulopathy Coagulopathy
Raised CSF IL-6
Raised rectal temperature
(fever)
Raised temperature (fever)
Clinical
findings
Sweatiness (fever) Fever
Recent gastrointestinal or
respiratory viral infection
Underlying infection
Physiological
findings
Hypoxemia, tachycardia then
bradycardia, asystole,
gasping, death
Hypoxemia, tachycardia then
bradycardia, asystole, gasping,
death
Raised rectal temperature Fever
Microbiological
findings
Normally sterile site infection Normally sterile site infection
Evidence of bacteremia Bacteremia
Risk factors Genetic (various; immune
gene polymorphisms)
Genetic (various)
Prenatal (exposure to smoke
products)
Prenatal (various)
Postnatal (exposure to smoke
products, prone sleep, etc.)
Postnatal (smoking,
immunopathy)
?, undetermined.
Role of Gut Microbiome During the Critical
Developmental Period Associated with
SIDS
Colonization
Bacterial colonization of the human infant colon is influenced by
many factors – age, mode of delivery (23), diet, environment, and
antibiotic exposure (20, 21, 24–26).
There is growing evidence that cesarean section (CS) (not
regarded as a SIDS risk factor when controlled for gestational
age) (27) is linked to an impoverishment of natural development
of the immune system. Exposure of the neonatal gut to bacterial
priming (as occurs with vaginal delivery) appears to be missed in
babies born via CS (28). One of the main associations with CS is
low gestational age. Prematurity remains a significant and largely
unexplained risk factor for SIDS; the vulnerable, immature host
notwithstanding (29). It is presumed that the abovementioned
mechanisms (27) over and above the vulnerable host would go
some way to explain this increased risk.
Diet influences the gut microbiota. The effect of breast milk
on the infant immune system is considered to derive benefit via
its effect on gut bacterial colonization (30). Breast feeding has
a protective effect against SIDS and given the effects on the gut
microbiota, suggests that these bacteria might play a role in addi-
tion to maternally transferred cellular and humoral immunity. CS
remains the most common mode of delivery of preterm infants.
The possibility that these babies will receive breast milk or enteral
feeds remains remote while the opposite is true for receiving treat-
ment with antibiotics. Animal studies show that a lack of enteral
nutrition may be associated with an increased risk of septic shock
due to bacterial translocation caused by intestinal epithelial cell
apoptosis (31). These factors thus adversely affect preterm infants
in terms of their susceptibility to infection and to inflammatory
gut disease such as necrotizing enterocolitis (NEC) (30). Because
SIDS infants are more likely to have had symptoms of infectious
diseases in the last week or the last day before death, they are
more often examined by a physician and given antibiotics than
control babies (32). It remains unknown if antibiotics specifically
contribute to the risk of SIDS.
Gut Immunology and Homeostasis
The intestinal immune system is modulated in response to envi-
ronmental factors shortly after birth (33). Battersby and Gibbons
(34) summarized the emerging knowledge of how the gut main-
tains immune homeostasis with non-pathogenic bacteria (34). A
better understanding of the molecular and cellular mechanisms
sustaining homeostasis is emerging (35–37).
Mechanisms by Which the Gut Microbiome
Could Induce Inflammation and Transit of
Bacteria to the Blood Stream
Microbial Recognition and Inflammation
The nuclear factor kappa B (NF-κB) pathway is responsible for
microbial recognition and inflammatory responses in the adult
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gut. NF-κB, the so-called “master switch” of the immune system,
has numerous roles in innate and adaptive immune responses and
inflammation. In the mature gut, pathogen-activated molecular
patterns (PAMP)-specific region of a gut pathogen binds to its
corresponding Toll-like receptor (TLR) on an enterocyte (EC) and
causes release of NF-κB (38). The reaction enters the nucleus
where genes mediating inflammation are turned on (38–40). In
response to bacterial lipopolysaccharide (LPS), fetal ECs upreg-
ulate the NF-κB pathway and produce more of the chemokines,
CXCL2 and CXCL8 (41).
Tolerance and Commensal Bacteria
First exposure of the neonatal gut to LPS and antigens from
non-pathogenic commensals may result in significant inflam-
matory responses. The mechanisms by which tolerance to non-
pathogenic commensals is established at this most critical period
require further understanding. Part of the process includes inhi-
bition of the NF-κB pathway by commensal bacteria (40, 42).
As ECs mature, expression of surface TLRs reduces, as do
downstream signaling complexes, while inhibitory factor kappa
(iκB), a negative regulator, increases. This appears to provide
“protection” without adverse inflammation during colonization
(43). Alterations in innate immune response genes in fetal ECs
contribute to NEC (44) and suggest that an inappropriate inflam-
matory response takes place in premature babies. Commensal
bacteria exert a variety of effects on cytokine responses. These
include production of pro-inflammatory cytokines via the IL-
25–IL-23–IL-17 axis (45), possible downregulation of IL-17 in
Th-17 cells resulting in diminished inflammation, and upreg-
ulation of IL-25. IL-25 is thought to suppress IL-23 by gut
dendritic cells (DCs) with subsequent diminished IL-17 and an
anti-inflammatory effect (45). Commensal bacteria also affect
responses of CD103+ DCs to products of ECs (such as retinoic
acid, TDF-β, and cytokine thymic stromal lymphopoietin (TSLP)
that effectively dampen the adaptive immune response in those
(46). In addition, commensal bacteria (such as Bifidobacterium
sp.) may upregulate IL-10 production by DCs (47).
Pathogen Recognition
Pathogen recognition by innate immune cells initiates an immune
response to infection. Key PAMPs instigate effector responses
through activation of pathogen pattern recognition receptors
(PRRs), which include well-characterized TLRs. Adults and chil-
dren carry an increased infection risk if they carry TLR polymor-
phisms. The same is true for SIDS (48). Neonatal infection with
Gram-positive and Gram-negative bacterial infections is associ-
ated with enhanced expression of TLR2 and TLR4 (38). Dysregu-
lation of TLR4 expression is associated with development of NEC
(49), commonly associated with neonatal sepsis. In addition to
activation by exogenous PAMPs such as LPS or viral ssDNA, TLRs
occurs through endogenous damage- or danger-associatedmolec-
ular patterns (DAMPs), intracellular proteins, and inflammatory
mediators released by damaged or apoptotic cells. These include
endogenous AlarminHigh-Mobility Group Box 1 (HMGB1), heat
shock proteins, and uric acid; each contributes to the pathophysi-
ology of septic shock.DysregulatedHMGB1 expression associated
with progression of sepsis to septic shock (43, 50) perpetuates
the inflammatory response. Disruption of EC tight junctions also
occurs and leads to increased bacterial translocation (51) and
bacteremia.
Recognition of PAMPS orDAMPS by PRRs results in activation
of NFkB resulting in pro-inflammatory cytokine and chemokine
production and induction of the IRF transcription factors that
mediate production of type I interferon. The NOD-like receptor
(NLR) family of proteins shares a number of common domains
and many are involved in PAMP and DAMP sensing. The process
results in NFkB activation and inflammatory gene expression
(52, 53). NLRP proteins oligomerize directly or indirectly with
caspase1 through the caspase recruitment domain (CARD) to
form an inflammasome. Inflammasomes are essentially caspase-
activating complexes.
The anti-inflammatory nature of IL-10 is well known, except,
perhaps in SIDS where the cytokine might contribute to a fatally
defective pathogen recognition (48). In the neonatal gut, IL-10 is
reported to reduce inflammation as evidenced by inhibition of key
parts of the unfolded protein response (UPR) (38, 54). Paneth and
goblet cells respond to abnormal protein handling with the UPR,
which results in local tissue inflammation through activation of
immune cells including neutrophils (55).
Role of Innate Lymphoid Cells
These cells do not possess a specific antigen receptor; however,
innate lymphoid cells (ILCs) are able to secrete a number of
cytokines equivalent to those produced by the subsets (subsets
TH2, TH17, and TH22.) of T helper cells. Subsets of ILCs have
been demonstrated. ILC1 cells differ from natural killer (NK)
cells in that they lack CD56, CD16, and CD94 NK cell markers
as well as perforin, and granzyme B. ILCs function in lymphoid
organogenesis, tissue remodeling, antimicrobial immunity, and
inflammation, particularly at barrier surfaces (56). Their ability to
respond promptly to insults inflicted by stress-causing microbes
strongly suggests that ILCs are critical in first-line immunological
defenses. A number of families of ILCs have been described.
These include Rorγt-expressing cells involved in lymphoid tissue
formation, mucosal immunity, and inflammation. Type 2 ILCs are
important for helminth immunity, type 3 for mucosal integrity
and healing.
Gut homeostasis depends on minimizing responses to com-
mensal bacteria, which can lead to inflammatory bowel disease
(IBD) in genetically predisposed individuals; but there is a need
to retain the ability to recognize and control the growth of infec-
tious pathogens (56). Group 3 innate lymphoid cells (ILC3) help
maintain intestinal homeostasis by producing the cytokine IL-22,
which promotes mucosal healing and maintains barrier integrity.
Microbial signals trigger production of IL-23 and IL-1β; these
stimulate ILC3s to produce IL-22, leading to induction of antibac-
terial peptides and epithelial cell regeneration (57). The cell type
producing IL-23 in response to microbial signals is unclear and
muchdebated; residentmononuclear phagocytes (MNPs), inflam-
matory monocytes, and conventional DCs have all been impli-
cated. Longman et al. (57) provide a clue. Inmice withClostridium
rodentium infection and in patients with colitis, CX3CR1+ MNPs
are superior producers of IL-23 and IL-1β, and they are very
efficient in inducing IL-22 production by ILC3 (56, 58).
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The development of Peyer’s patches and ILC2 and ILC3 sub-
sets depends on Nfil3 (nuclear factor, interleukin 3-regulated).
Loss of Nfil3 selectively decreases Peyer’s patch formation and
is associated with defective recruitment and distribution of ILCs
within the patches. ILC subsets strongly express Nfil3. Deletion
of Nfil3 genes adversely affects development of all subsets, so that
Nfil3-/- knockout mice show increased susceptibility to infection
or pro-inflammatory agents confirming the importance of the
role of Nfil3 in development of ILC subsets upon which the gut
depends for protective immunity (59), especially against intestinal
pathogens (60). Additionally, development of all innate lymphoid
cell subsets depends on Nfil3.
Gut Microbiome, Inflammation, and SIDS
The microbiome contributes to development and sustenance of
the immune system. This includes protective immune effector
function in the healthy host as well as in cases of disease. It is
noted that SIDS cases frequently have been unwell in the days
leading up to the death. Diarrheal symptoms are often reported
(61). Bacteremia associated with viral gastroenteritis often with
an accompanying fever is a known complication (62). Bacteremia
without localizing source is also well known (63), and occult
bacteremia is not uncommon in infancy (64). Such episodes
of bacteremia are usually benign, indicating that most babies’
immune responses are able to cope without lethal consequences.
By contrast, SIDS babies might have dysregulated responses (48).
In these circumstances, it could be suggested that bacteremia
could result in an overwhelming cytokine storm with consequent
sepsis/toxemia resulting in the baby’s demise.
In addition to the pathogenic E. coli groups (Bettelheim and
Goldwater, this issue), two groups of the gut microbiome have
been investigated in relation to SIDS – Bacteroides thetaiotaomi-
cron and Clostridium species.
Gram-Negative Bacteria and Inflammation
It is known that the NLRC4 inflammasome is activated through
caspase1 by Gram-negative bacteria containing type III or type IV
secretion systems, e.g., Salmonella, Shigella, Legionella, Pseu-
domonas, Yersinia, and some E. coli. NLRC4 specifically recog-
nizes flagellin; consequently, non-motile strains are unable to
activate caspase1. Flagellin protein alone has been shown to acti-
vate caspase1. Caspase1 activation appears to be dependent on
a rod protein in the type III secretion system that contains a
flagellin-like motif (52, 53).
Translocation of bacteria through an inflamed gut wall lead-
ing to bacteremia sets the stage for further induction of pro-
inflammatory cytokines and perturbation of the clotting cascades.
As IL-6 is elevated in the CSF of SIDS cases (65), it is reasonable
to surmise that pro-inflammatory cytokines might be responsi-
ble for observed organ changes: brain microglial response (10);
increased brain weight; myocardial acute inflammatory reaction
(66). Pro-inflammatory cytokines are responsible for perturba-
tion of the clotting cascade and loss of endothelial integrity (67)
resulting in raised fibrin degradation products and the vascu-
lopathy evidenced as intrathoracic petechial hemorrhages. SIDS
babies frequently carry a low-producer polymorphism for the
anti-inflammatory cytokine IL-10 (68), which could contribute to
reduced control of pro-inflammatory cytokine release.
B. thetaiotaomicron
B. thetaiotaomicron, a Gram-negative obligate anaerobe, coloniz-
ing the human gut, is a major endosymbiont of the human gut.
It can hydrolyze and utilize as an energy source non-digestible
polysaccharides and maltooligosaccharides (69). It contributes to
bacteria–host symbiosis, postnatal intestinal development, phys-
iology and metabolism of the host (70), and development of the
immune system (71).
Bacteroides thetaiotaomicron is recognized as a major player
in the adult intestinal microbiome and is useful as a model for
the investigation of human–bacterial interactions. It degrades
plant polysaccharides. In the infant, it is important during tran-
sition from breast milk to a high plant starch diet. It has been
shown to stimulate intestinal angiogenesis in response to micro-
bial products reaching the Paneth cells (72). Postnatally, B.
thetaiotaomicron mediates formation of the mucosal gut bar-
rier assisting in protection against pathogenic invasion seem-
ingly through its effect on expression of species-specific protein
antibiotics (73). B. thetaiotaomicron allows for adaptive carbo-
hydrate foraging through its environmental sensing system (74).
This results in stabilized food webs, and sustenance of bacterial
communities (73). This could be important in protection against
bacteria and/or toxins purportedly involved in SIDS pathogene-
sis. The species has been identified among a higher proportion
of SIDS infants (30%) compared with control healthy babies
(8.8%) (17).
Clostridium spp
Lecithinase-positive clostridia and other clostridia are found sig-
nificantly more often in formula-fed babies than breast-fed babies
(75). Our study found SIDS babies had significantly higher rates
of colonization with these anaerobes than live comparison babies
(17). Formula feeding seemed to show a trend toward higher
colonization rates with clostridia than breastfeeding (17). The role
of clostridia in gut inflammation is discussed below. In the context
of inflammation, the review by Schuijt et al. (76) considered
the hypothesis that the gut has an important detrimental role in
promoting systemic inflammation and infection in the critically
ill. They demonstrated that during stress andmucosal hypoxia, the
mucosa is damaged and host defenses break down allowing bac-
teria and toxin translocation thought to produce overwhelming
inflammation, sepsis, and multiorgan failure (77, 78).
Evidence of Infection in SIDS
Babies dying of SIDS are reported to have sweat-soaked clothing
and bedding indicating a febrile episode in the last sleep (61). Rec-
tal temperatures at autopsy of SIDS babies are elevated providing
further evidence of fever during the last sleep (79). The basis for
a link between the gut microbiome and SIDS is founded upon a
substantial body of published evidence and congruence with fac-
tors associated with sepsis (Table 1). This provides an explanatory
scheme for underlying pathogenic mechanisms involved in events
leading to SIDS.
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Pathological Findings
Consistent pathological findings include intrathoracic petechiae;
liquid heart blood; heavy wet lungs; large heavy brain with
microglial response (10); acute myocardial inflammatory reaction
(66); elevated fibrin degradation products (80); and recent viral
infection (61). These suggest a single, common patho-mechanism
(5, 6). The finding of S. aureus and E. coli and other coliforms in
normally sterile sites (66, 81, 82) supports the idea of bacteremia
occurring as a plausible near-terminal event. Morris’ Common
Bacterial Toxin Hypothesis (1, 2, 83) first indicated a key role of
bacteremia in the final pathway. How the purported bacteremia
arises seems to implicate gut integrity/permeability/immunity,
which depend on the gutmicrobiome (84). Potentially, pathogenic
Clostridia species are over-represented in SIDS babies (17); these
could influence the integrity of the gut wall through either
induction of an inflammatory response or mechanism involving
disruption of EC tight junctions leading to increased bacterial
translocation (51).
Inflammation and Pro-inflammatory Cytokines
Inflammasomes are thought to be key in induction of inflamma-
tion through production of pro-inflammatory cytokines. Secre-
tion of IL-1β mediates recruitment of cells to the site of proposed
clostridia-mediated insult and could play a role in SIDS (52, 53).
While gut inflammation is considered to be primary in the
events leading to SIDS, the other side of the equation is defec-
tive responses to infection, e.g., a defective pathogen recognition
pathway.
Clinico-Physiological Events in SIDS
The clinical/physiological events observed in SIDS cases captured
on memory monitors (85) can be explained by development of
septic/toxic shock resulting from the release of pro-inflammatory
cytokines secondary to a bacteremic episode or toxemia. These
include fever, tachycardia followed by profound bradycardia,
hypoxemia, and gasping (after asystole) (85).
Evidence of Bacteremia/Toxemia in SIDS Infants
The relatively low rate of sterile site infection (16–19% of SIDS
cases) could argue against the bacteremia hypothesis. The find-
ing of viable bacteria in a normally sterile site depends on the
bacteria’s cultivability. Most of the gut microbiota are unlikely to
grow on standard diagnostic artificial culture media (86), and this
could contribute to low-positive culture rates. It remains highly
probable that non-cultivable bacteria entering the blood stream
could induce the cytokine storm thought to underlie the final
events in SIDS.
Brain and Heart Abnormalities in SIDS
The findings of brain abnormality (87) and of smaller than nor-
mal heart and kidneys (88) seem to relate to abnormal prenatal
development. This was refuted by Guntheroth and Spiers (89)
and needs to be revisited. The smaller than normal heart (with
accompanying possible predisposition to arrythmia) could make
the infant more vulnerable to profound immuno-inflammatory
events associated with bacteremia/sepsis.
SIDS Risk Factors
Risk factors for SIDS can be categorized into genetic, prena-
tal, and postnatal. These have been described previously (5, 6).
Why prone sleep position is a risk factor has been explained by
the acquisition of bacteria from contaminated surfaces (sofas,
parental bed, being especially contaminated and high risk) (17). It
is important to note that data purportedly showing a relationship
between bedsharing and SIDS and inferring overlaying/asphyxia
as cause (90) needs re-examination because the reason for bed-
sharing remains poorly described in published studies. It could
be interpreted that bedsharing on the night of the last sleep
came about because the baby was unsettled or unwell, indicat-
ing subtle symptoms of infection. This is supported in a sys-
tematic review of bed sharing in which illness and crying were
frequently reported (91). The role of alcohol and drugs by co-
sleeping parent(s) has also been interpreted as leading to over-
laying. The alternative suggestion of lessened awareness in the
co-sleeping parent might lead to failure to notice subtle symp-
toms of illness in the baby. Using overlaying with consequent
asphyxiation as the major explanation of the risk factor of bed-
sharing requires re-evaluation. Mainstream researchers attribute
a “respiratory” cause for intrathoracic petechiae. Differentiation
between the intrathoracic petechiae observed in asphyxia and
SIDS have been well described (92, 93) and show clear dif-
ferences; yet, these findings are largely ignored by mainstream
researchers.
Future Research
Delineation of the gut microbiome in SIDS and healthy babies
might provide additional clues to the processes underlying the
role of the gut in SUDI. Extended immunohistological exam-
ination of the gut wall for evidence of ILCs and subtle gut
inflammatory changes in SIDS babies might provide evidence
of inflammation contributing to a functional failure of the gut
wall to prevent bacterial translocation from the gut lumen into
the bloodstream. Nfil3 gene polymorphisms should be sought
as these could contribute to gut vulnerability. In the context
of bacteremia, efforts using PCR technology should be made
to exclude/demonstrate the presence of non-cultivable bacte-
ria in normally sterile sites. The gut microbiome observed in
SIDS might correlate with the presence of ILCs and a “pro-
inflammatory gut microbiome.” Such findings might contribute
to a new definition of SIDS. The corollary of establishing a pos-
sible “anti-inflammatory” gut microbiome in healthy babies via
diet or other means (pre- or probiotic) could be explored as a
“natural” mechanism of protecting babies in the future but not
forgetting the messages advocating a safe sleeping environment
and parental avoidance of cigarette smoke and other harmful
drugs.
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